FRM
Fox Run Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Sell |
13,967
-1,745
| -11% | -$30.2K | 0.04% | 703 |
|
|
2025
Q1 | $344K | Buy |
+15,712
| New | +$344K | 0.05% | 629 |
|
|
2024
Q3 | – | Sell |
-22,102
| Closed | -$848K | – | 786 |
|
|
2024
Q2 | $848K | Buy |
+22,102
| New | +$848K | 0.16% | 231 |
|
|
2024
Q1 | – | Sell |
-5,235
| Closed | -$313K | – | 739 |
|
|
2023
Q4 | $313K | Sell |
5,235
-1,198
| -19% | -$71.7K | 0.08% | 481 |
|
|
2023
Q3 | $245K | Buy |
6,433
+4,136
| +180% | +$157K | 0.07% | 509 |
|
|
2023
Q2 | $209K | Buy |
+2,297
| New | +$209K | 0.06% | 570 |
|
|
2022
Q4 | – | Sell |
-10,819
| Closed | -$739K | – | 603 |
|
|
2022
Q3 | $739K | Buy |
+10,819
| New | +$739K | 0.29% | 67 |
|